Article
Objective assessment, drugs improve bladder symptoms
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Pivotal data for lumasiran in PH1 published in NEJM
Nedosiran explored in primary hyperoxaluria type 3
Enrollment completed in pivotal trial of nedosiran for hyperoxaluria
FDA approves androgen inhibitor for metastatic PCa
Blood test could guide treatment for kidney cancer
BCG for bladder cancer in short supply
Aquablation procedures for prostate cancer completed at ambulatory surgery center
FDA grants priority review to expanded indication of flibanserin in HSDD
FDA clears image-guided navigation platform for focal therapy in prostate cancer
Category III CPT code issued for Enhanced Lithotripsy System